✦ LIBER ✦

Use of a combination of computed tomography and endoscopy to assess the response to 5-fluorouracil/cisplatin and predict survival in gastric cancer

✍ Scribed by Sook Ryun Park; Il Ju Choi; Chan Gyoo Kim; Young-Woo Kim; Keun Won Ryu; Jun Ho Lee; Jong Seok Lee; Jae-Moon Bae; Hark Kyun Kim

Publisher: Springer Japan
Year: 2006
Tongue: English
Weight: 264 KB
Volume: 41
Category: Article
ISSN: 0944-1174
DOI: 10.1007/s00535-005-1759-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Predictive factors of response to cispla

Predictive factors of response to cisplatin-based chemotherapy and the relation of response to survival in patients with metastatic urothelial cancer

✍ Lisa Sengeløv; Claus Kamby; Poul Geertsen; Lisbeth Juhler Andersen; Hans von der 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 108 KB

A metabonomic approach to chemosensitivi

A metabonomic approach to chemosensitivity prediction of cisplatin plus 5-fluorouracil in a human xenograft model of gastric cancer

✍ Xi Wang; Shi-Kai Yan; Wei-Xing Dai; Xin-Ru Liu; Wei-Dong Zhang; Jie-Jun Wang 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 738 KB

## Abstract The prediction of chemosensitivity is a challenging problem in the management of cancer. In the present study, a metabonomic approach was proposed to assess the feasibility of chemosensitivity prediction in a human xenograft model of gastric cancer. BALB/c‐nu/nu mice were transplanted w

High rate of clinical complete response

High rate of clinical complete response to weekly outpatient neoadjuvant chemotherapy in oral carcinoma patients using a new regimen of cisplatin, 5-fluorouracil, and bleomycin alternating with methotrexate and epirubicin

✍ Jin-Ching Lin; Jian-Sheng Jan; Chen-Yi Hsu; Daniel Yong-Kie Wong 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 244 KB 👁 2 views

A Phase II trial was initiated to evaluate the response to and toxicity of a new regimen of weekly outpatient neoadjuvant chemotherapy in patients with oral carcinoma. ## METHODS. Patients with previously untreated squamous cell carcinoma of the oral cavity were eligible for this trial. The neoad

N1-(2 tetrahydrofuryl)-5-fluorouracil (f

N1-(2 tetrahydrofuryl)-5-fluorouracil (ft-207) in the postoperative adjuvant chemotherapy of gastric cancer. Delivery of a fat-emulsified agent to the lymph

✍ Hitoshi Hanaue; Tsutomu Kurosawa; Yoshiaki Kitano; Sadaaki Miyakawa; Fumitoshi H 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 532 KB

The use of clonogenic assays in assessin

The use of clonogenic assays in assessing the response of human lung cancer cell lines to α and γ interferons alone or in combination with adriamycin

✍ S. A. B. Jabbar; P. R. Twentyman 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 French ⚖ 603 KB

Determination of the maximum tolerated d

Determination of the maximum tolerated dose of idarubicin when used in a combination chemotherapy program of reinduction of childhood ALL at first marrow relapse and a preliminary assessment of toxicity compared to that of daunorubicin: A report from the childrens cancer study group

✍ Feig, Stephen A. ;Krailo, Mark D. ;Harris, Richard E. ;Baum, Edward ;Holcenberg, 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 566 KB

## Abstract An escalating‐dose trial of idarubicin, used weekly for 3 doses in combination with vincristine, prednisone, and L‐asparaginase (VPLI), to reinduce remission of childhood ALL at first bone marrow relapse was conducted by the Childrens Cancer Study Group (CCSG). The maximum tolerated dos